Annotated Medicine and Device Lists

Neostigmine

Injection 500 mcg in 1-mL ampoule Injection 2.5 mg (metilsulfate) in 1-ml ampoule Injection 500 mcg (methylsulfate) in 1-mL ampoule Tablet 15 mg (bromide)

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS	No observations
Bolivia	LINAME 2011 - 2013	No observations
Ecuador	Essential Medicines List - Ecuador	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS	No observations

This medicine is present in:

List	Section	Observation
Peru	20.1 Peripherally Acting Cholinesterase Inhibitors and Muscle Relaxants	No observations
Chile	Essential and Prioritized Medications	No observations
Colombia	2.6 Cholinesterase Inhibitors	No observations
Cuba	20. RELAJANTES MUSCULARES E INHIBIDORES DE LA COLINESTERASA	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS	No observations
Peru	20.1 Peripherally Acting Cholinesterase Inhibitors and Muscle Relaxants	No observations
Chile	Essential and Prioritized Medications	No observations

Information Resources: Neostigmine

No information available